ClinicalTrials.gg
CompletedNCT07155876Updated Oct 6, 2026

Exploring the Effect of Aromatherapy

An interventional study of Aromatherapy plus standard of care and Standard of Care Only in Anxiety, Labor Pain and Nausea and Vomiting, sponsored by Baptist Health South Florida. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.

Primary conditionLabor PainRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Labor Pain
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Labor Pain.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Baptist Health South Florida · Not applicable, Interventional, and Treatment

Updated Oct 6, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 81 studies in Labor Pain with a site in United States — 7 open to participants now, 8 under way, none of them phase 3. Labor Pain · United States.

Enrollment
22nd of 70
138 · median 100
Started
2025
with 1 other
No phase
39 of 81
4 open now
Registered
80th of 81
by date

Among the 81 studies in Labor Pain with a site in United States, this one is the 22nd largest by enrollment of the 70 interventional ones that give a count, is one of 2 that started in 2025, is one of 39 with no phase, and was the 80th registered.

Labor Pain

423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.

Browse Labor Pain studies →

Open to participants now

7 of the 81 studies in Labor Pain with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 30 Labor Pain studies recruiting now, 8 (27%) set no upper age limit and 22 (73%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Labor Pain with a site in United States, or all of them as a file.
02

Study summary

To explore the effect of aromatherapy in laboring patients with pain, anxiety, and/or nausea/vomiting.

03

Conditions studied

  • Anxiety
  • Labor Pain
  • Nausea and Vomiting

Browse trials for

04

In context

Labor Pain Reclassified

423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.

This study's enrollment of 138 is above the median of 100 across 347 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Baptist Health South Florida is the lead sponsor of 52 studies on the registry; 18 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.

Compared within Labor Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant patients at least 18 years old in spontaneous labor or induction of labor (despite transitioning into a caesarean section)

Exclusion criteria

Exclusion Criteria:

  • Patients who are unable to detect scents/odors
  • Patients with known allergies to aromatherapy and/or its components
06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
138 participants (actual)

Study arms

  • Experimental
    Intervention group: Education video

    The participant receives aromatherapy plus standard of care (SoC) for treatment based on symptoms (anxiety, pain, and/or nausea/vomiting) as prescribed by the physician.

    Other: Aromatherapy plus standard of care

  • Other
    Control group: Standard of Care

    The patient receives SoC for treatment of based on symptoms (anxiety, pain, and/or nausea/vomiting) as prescribed by the physician.

    Other: Standard of Care Only

Interventions

  • OtherAromatherapy plus standard of care

    The participant is offered an aromatherapy scented tab that is attached to their gown based on symptoms (anxiety, pain, and/or nausea/vomiting): 1. Pain or anxiety: lavender or lavender sandalwood, 2. Nausea/vomiting: orange ginger, or 3. Despite the type of discomfort, the participant may request the alternate scent if the scent offered is not to their liking. Plus, the patient receives SoC for treatment based on symptoms (anxiety, pain, and/or nausea/vomiting) as prescribed by the physician.

  • OtherStandard of Care Only

    Participant receives symptom management medications for pain, nausea/vomiting, and/or anxiety as prescribed by the physician.

07

What researchers measure

Primary outcomes

  1. Relief of nausea/vomiting

    Measured in the control and intervention groups before and after receiving treatment (yes or no - presence of nausea/vomiting).

    Time frame: Measured before and after receiving standard of care (SoC) or Intervention+SoC.

  2. Decreased anxiety

    Measured before and after receiving treatment in both the control and intervention groups. Anxiety level = 0 =none, 1 = minimal (a little), 2 = moderate (medium), and 3 = severe (a lot).

    Time frame: Measured before and after receiving standard of care (SoC) or Intervention+SoC.

  3. Pain relief (scale of 0 to 10)

    Level of pain is measured before and after receiving treatment in both the control and interventions groups. Pain is measured on a scale of 0 to 10 (0 = no pain, 10 = severe pain).

    Time frame: Measured before and after receiving standard of care (SoC) or Intervention+SoC.

08

Study locations

1 site
  • South Miami Hospital
    Miami, Florida 33143, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2025 to primary completion in Sep 2026, 11 months.

Of 191 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's 11 months is above that.

Counting every sponsor, half of 193 studies reached it within 9 months; a quarter within 5 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2025
First posted
Sep 4, 2025
StartActual
Oct 15, 2025
Primary completionActual
Sep 24, 2026
CompletionActual
Sep 24, 2026
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Oct 6, 2026
Primary completion
Sep 1, 2026→Sep 24, 2026 (actual)
Oct 6, 2026
Study completion
Sep 1, 2026→Sep 24, 2026 (actual)
Oct 6, 2026
Enrollment
128 (estimated)→138 (actual)
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Enrolling by invitation→Completed
    Primary completion Sep 1, 2026→Sep 24, 2026 (now actual)
    Study completion Sep 1, 2026→Sep 24, 2026 (now actual)
    Enrollment 128 (estimated)→138 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07155876
Lead sponsor
Baptist Health South Florida
Responsible party
Sponsor
First posted
Sep 4, 2025
Start date
Oct 15, 2025
Primary completion
Sep 24, 2026
Completion
Sep 24, 2026
Last update
Oct 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion